These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2424121)

  • 21. [Role of pentosan polysulfate in initiating 2 cases of thrombopenic complications].
    Maiza D; Derlon A; Khayat MC; Coulhon JP; Leporrier M
    Presse Med; 1985 Jun; 14(23):1289-90. PubMed ID: 2409548
    [No Abstract]   [Full Text] [Related]  

  • 22. Molecular weight of heparin versus biologic activity. Some additional considerations.
    Losito R; Losito C
    Semin Thromb Hemost; 1985 Jan; 11(1):29-33. PubMed ID: 2579437
    [No Abstract]   [Full Text] [Related]  

  • 23. [Thrombopenia and fatal intracerebral hemorrhage caused by pentosan polysulfate].
    Rosenthal E; Tiger F; Benoit P; Quaranta J; Bayle J; Grimaud D
    Presse Med; 1988 Jan; 17(3):126. PubMed ID: 2450343
    [No Abstract]   [Full Text] [Related]  

  • 24. Pentosan induced cerebral sagittal sinus thrombosis: a variant of heparin induced thrombocytopenia.
    Rice L; Kennedy D; Veach A
    J Urol; 1998 Dec; 160(6 Pt 1):2148. PubMed ID: 9817346
    [No Abstract]   [Full Text] [Related]  

  • 25. Heparin-induced immune thrombocytopenia.
    Babcock RB; Dumper CW; Scharfman WB
    N Engl J Med; 1976 Jul; 295(5):237-41. PubMed ID: 945459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison between heparin and a heparin analogue (sodium pentosan polysulphate) in the initial treatment of deep vein thrombosis. Preliminary communication.
    Bergqvist D; Falke P; Jaroszewski H; Lamme S
    Vasa; 1986; 15(1):77-80. PubMed ID: 2421498
    [No Abstract]   [Full Text] [Related]  

  • 27. Thrombocytopenia with or without thrombosis after pentosan polysulfate treatment.
    Claisse JF; Andrejak M; Jarry G; Desablens B; Roussel B; Delobel J
    Therapie; 1990; 45(6):514-5. PubMed ID: 1706895
    [No Abstract]   [Full Text] [Related]  

  • 28. [Does the pentosan polysulfate-heparin have a thrombolytic action?].
    Pinot JJ; Sampol J
    Presse Med; 1986 Oct; 15(33):1683. PubMed ID: 2431405
    [No Abstract]   [Full Text] [Related]  

  • 29. Heparin-associated thrombocytopenia treatment with low molecular weight heparin.
    Vitoux JF; Mathieu JF; Roncato M; Fiessinger JN; Aiach M
    Thromb Haemost; 1986 Feb; 55(1):37-9. PubMed ID: 3705006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison between the effect of pentosan polysulphate heparin and antithrombin III injections in antithrombin III deficient patients.
    Fischer AM; Dautzenberg MD; Aurousseau MH; Béguin S; Goudemand J; Hemker HC
    Thromb Res; 1985 Jan; 37(2):295-307. PubMed ID: 2579452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of pentosan polysulphate and heparin. II: Effects of subcutaneous injection.
    Fischer AM; Merton RE; Marsh NA; Williams S; Gaffney PJ; Barrowcliffe TW; Thomas DP
    Thromb Haemost; 1982 Apr; 47(2):109-13. PubMed ID: 6179183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cold-reactive platelet agglutinins.
    Farkas JC; Brossel C; Boyer JM; Brisset D; Laurian C
    Thromb Haemost; 1993 Nov; 70(5):879-80. PubMed ID: 8128452
    [No Abstract]   [Full Text] [Related]  

  • 33. Release of plasminogen activator by pentosan polysulphate.
    Klöcking HP; Markwardt F
    Thromb Res; 1986 Mar; 41(5):739-44. PubMed ID: 2421436
    [No Abstract]   [Full Text] [Related]  

  • 34. Fibrinogen binding on human platelets. Influence of different heparins and of pentosane polysulfate.
    Dunn F; Soria J; Soria C; Thomaidis A; Tobelem G; Caen JP
    Thromb Res; 1983 Jan; 29(2):141-8. PubMed ID: 6189236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of heparin cofactor II as the principal plasma cofactor for the antithrombin activity of pentosan polysulphate (SP54).
    Scully MF; Kakkar VV
    Thromb Res; 1984 Oct; 36(2):187-94. PubMed ID: 6209821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tolerance to the synthetic pentasaccharide fondaparinux in heparin sensitization.
    Sacher C; Hunzelmann N
    Allergy; 2003 Dec; 58(12):1318-9. PubMed ID: 14616114
    [No Abstract]   [Full Text] [Related]  

  • 37. Heparin-related immune thrombocytopenia. Studies of antibody-heparin specificity.
    Trowbridge AA; Caraveo J; Green JB; Amaral B; Stone MJ
    Am J Med; 1978 Aug; 65(2):277-83. PubMed ID: 80131
    [No Abstract]   [Full Text] [Related]  

  • 38. Heparin- and streptokinase-dependent platelet-activating immunoglobulin G: mechanism and diagnosis.
    Lecompte T; Stieltjes N; Shao-Kai L; Morel MC; Kaplan C; Samama MM
    Semin Thromb Hemost; 1995; 21(1):95-105. PubMed ID: 7604296
    [No Abstract]   [Full Text] [Related]  

  • 39. [Cerebral infarction as first manifestation of thrombocytopenia caused by pentosan polysulfate].
    Gironell A; Arboix A; Altés A; Martí-Vilalta JL
    Med Clin (Barc); 1997 Apr; 108(16):636. PubMed ID: 9303962
    [No Abstract]   [Full Text] [Related]  

  • 40. The antiheparin effect of a heparinoid, pentosan polysulphate. Investigation of a mechanism.
    Scully MF; Kakkar VV
    Biochem J; 1984 Mar; 218(3):657-65. PubMed ID: 6202294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.